Green Thumb Industries (GTBIF) Other Non Operating Income (2019 - 2026)
Green Thumb Industries (GTBIF) posted Other Non Operating Income of $23.0 million for Q1 2026, up 245.85% on a QoQ basis from -$15.7 million in Q4 2025, and up 95795.83% year-over-year from N/an in Q1 2025.
Green Thumb Industries (GTBIF) Other Non Operating Income (2019 - 2026) Analysis & Trends
Green Thumb Industries' Other Non Operating Income history runs 8 years deep, the most recent figure standing at $23.0 million for Q1 2026.
- Quarterly Other Non Operating Income rose 95795.83% year-over-year to $23.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.3 million (up 526.12% YoY) and the FY2025 annual result came in at $8.4 million, up 191.82% from the prior year.
- Other Non Operating Income was $23.0 million for Q1 2026 at Green Thumb Industries, up from -$15.7 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $38.1 million in Q3 2025 and bottomed at -$16.2 million in Q4 2023.
- A 5-year average of $618529.4 and a median of -$290000.0 in 2024 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income tumbled 1296.56% — and 2026, when it jumped 95795.83%.
- Green Thumb Industries' Other Non Operating Income stood at -$10.4 million in 2022, then tumbled by 55.55% to -$16.2 million in 2023, then soared by 41.44% to -$9.5 million in 2024, then sank by 65.67% to -$15.7 million in 2025, then jumped by 245.85% to $23.0 million in 2026.
- Business Quant data shows GTBIF's Other Non Operating Income at $23.0 million in Q1 2026, -$15.7 million in Q4 2025, and $38.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.97 Mn |
| Dec 31, 2025 | -15.75 Mn |
| Sep 30, 2025 | 38.11 Mn |
| Jun 30, 2025 | -13.99 Mn |
| Mar 31, 2025 | -24,000.00 |
| Dec 31, 2024 | -9.51 Mn |
| Sep 30, 2024 | -290,000.00 |
| Jun 30, 2024 | 2.46 Mn |
| Mar 31, 2024 | -1.76 Mn |
| Dec 31, 2023 | -16.23 Mn |
| Sep 30, 2023 | -631,000.00 |
| Jun 30, 2023 | -270,000.00 |
| Mar 31, 2023 | 924,000.00 |
| Dec 31, 2022 | -10.43 Mn |
| Sep 30, 2022 | -2.09 Mn |
| Jun 30, 2022 | 5.58 Mn |
| Mar 31, 2022 | 11.44 Mn |
| Dec 31, 2021 | 872,000.00 |
| Jun 30, 2021 | 6.83 Mn |
| Mar 31, 2021 | -5.15 Mn |